Gene Symbol | IGFBP5 |
Entrez ID | 3488 |
Uniprot ID | P24593 |
Description | insulin like growth factor binding protein 5 |
Chromosomal Location | chr2: 216,672,105-216,695,525 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001558 |
regulation of cell growth |
Any process that modulates the frequency, rate, extent or direction of cell growth. |
IEA |
BP |
GO:0001649 |
osteoblast differentiation |
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone. |
IEA |
BP |
GO:0006006 |
glucose metabolic process |
The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
IEA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
NAS |
BP |
GO:0007565 |
female pregnancy |
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
IEA |
BP |
GO:0007568 |
aging |
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
IEA |
BP |
GO:0010906 |
regulation of glucose metabolic process |
Any process that modulates the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. |
IEA |
BP |
GO:0014912 |
negative regulation of smooth muscle cell migration |
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration. |
IDA |
BP |
GO:0017148 |
negative regulation of translation |
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA. |
IDA |
BP |
GO:0030336 |
negative regulation of cell migration |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration. |
IDA |
BP |
GO:0031069 |
hair follicle morphogenesis |
The process in which the anatomical structures of the hair follicle are generated and organized. |
IEA |
BP |
GO:0035556 |
intracellular signal transduction |
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
IEA |
BP |
GO:0042593 |
glucose homeostasis |
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
IEA |
BP |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway |
Any process that increases the frequency, rate or extent of insulin-like growth factor receptor signaling. |
IEA |
BP |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway |
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling. |
IDA |
BP |
GO:0044267 |
cellular protein metabolic process |
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
TAS |
BP |
GO:0044342 |
type B pancreatic cell proliferation |
The multiplication or reproduction of pancreatic B cells, resulting in the expansion of an pancreatic B cell population. Pancreatic B cell are cells of the pancreas that secrete insulin. |
IEA |
BP |
GO:0045668 |
negative regulation of osteoblast differentiation |
Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation. |
IEA |
BP |
GO:0045926 |
negative regulation of growth |
Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism. |
IEA |
BP |
GO:0048286 |
lung alveolus development |
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways. |
IEA |
BP |
GO:0048662 |
negative regulation of smooth muscle cell proliferation |
Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation. |
IDA |
BP |
GO:0051146 |
striated muscle cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle. |
IEA |
BP |
GO:0051897 |
positive regulation of protein kinase B signaling |
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
IEA |
BP |
GO:0060056 |
mammary gland involution |
The tissue remodeling that removes differentiated mammary epithelia during weaning. |
IEA |
BP |
GO:0060416 |
response to growth hormone |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth. |
ISS |
BP |
GO:0071320 |
cellular response to cAMP |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
IDA |
BP |
GO:0071407 |
cellular response to organic cyclic compound |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
IDA |
BP |
GO:1901862 |
negative regulation of muscle tissue development |
Any process that stops, prevents or reduces the frequency, rate or extent of muscle tissue development. |
IEA |
BP |
GO:1904205 |
negative regulation of skeletal muscle hypertrophy |
Any process that stops, prevents or reduces the frequency, rate or extent of skeletal muscle hypertrophy. |
IEA |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
NAS|TAS |
CC |
GO:0005622 |
intracellular |
The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
IEA |
CC |
GO:0016942 |
insulin-like growth factor binding protein complex |
A complex of proteins which includes the insulin-like growth factor (IGF) and a number of IGF-binding proteins. The complex plays a role in growth and development. |
IC |
CC |
GO:0042567 |
insulin-like growth factor ternary complex |
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development. |
IDA |
MF |
GO:0001968 |
fibronectin binding |
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids. |
IBA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0031994 |
insulin-like growth factor I binding |
Interacting selectively and non-covalently with insulin-like growth factor I. |
IPI |
MF |
GO:0031995 |
insulin-like growth factor II binding |
Interacting selectively and non-covalently with insulin-like growth factor II. |
IBA |
Domain ID | Description |
---|---|
IPR000716 |
Thyroglobulin type-1 |
IPR000867 |
Insulin-like growth factor-binding protein, IGFBP |
IPR009030 |
Growth factor receptor cysteine-rich domain |
IPR009168 |
Insulin-like growth factor binding protein |
IPR012213 |
Insulin-like growth factor binding protein 5 |
IPR017891 |
Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site |
IPR022321 |
Insulin-like growth factor-binding protein family 1-6, chordata |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
WP289 |
Myometrial Relaxation and Contraction Pathways |
WikiPathways |
WP3850 |
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling |
WikiPathways |
WP615 |
Senescence and Autophagy in Cancer |
WikiPathways |
h_ghrelinPathway |
Ghrelin: Regulation of Food Intake and Energy Homeostasis |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0005695 |
Bladder Neoplasm |
C0043094 |
Weight Gain |
C1458155 |
Mammary Neoplasms |
Tissue | Cell Type |
---|---|
adrenal gland |
glandular cells |
cerebellum |
cells in granular layer |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15820804 |
Oksjoki et al. |
2005 |
Molecular profiling of polycystic ovaries for markers of cell invasion and matrix turnover |
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22789864 |
Yan et al. |
2012 |
Expression of apoptosis-related genes in the endometrium of polycystic ovary syndrome patients during the window of implantation |
23824412 |
Piltonen et al. |
2013 |
Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
F2 |
2147 |
P00734 |
0.62 |
PAPPA2 |
60676 |
Q9BXP8 |
0.62 |
ATP1A1 |
476 |
P05023 |
0.63 |
BAG6 |
7917 |
P46379 |
0.63 |
RASSF1 |
11186 |
Q9NS23 |
0.63 |
PNO1 |
56902 |
Q9NRX1 |
0.63 |
KPNB1 |
3837 |
Q14974 |
0.52 |
TF |
7018 |
P02787 |
0.52 |
LTBP1 |
4052 |
Q14766 |
0.56 |
FHL1 |
2273 |
Q13642 |
0.63 |
FLNC |
2318 |
Q14315 |
0.63 |
IGF1 |
3479 |
P05019 |
0.63 |
FN1 |
2335 |
P02751 |
0.67 |
ADAM12 |
8038 |
O43184 |
0.67 |
THBS1 |
7057 |
P07996 |
0.75 |
VTN |
7448 |
P04004 |
0.75 |
SERPINE1 |
5054 |
P05121 |
0.85 |
IGF2 |
3481 |
P01344 |
0.86 |
IGFALS |
3483 |
P35858 |
0.86 |
SPP1 |
6696 |
P10451 |
0.86 |
FHL2 |
2274 |
Q14192 |
0.89 |